Larvol Delta - A-2Part-FirstinHuman-Study-to-Evaluate-the-Safety-Tolerability-Pharmacokinetics-and-Immunogenicity-of-CMTX101

CMTX-101 - Clarametyx Biosci

http://clinicaltrials.gov/ct2/show/NCT05629741

Jan 16, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next